5-ASA and Chemoprevention in Inflammatory Bowel Disease: A Population-Based Analysis

被引：0
|
作者：
Dorreen, Alastair [1 ]
Stewart, Samuel A. [1 ]
Lix, Lisa [2 ]
Jones, Jennifer [1 ]
机构：
[1] Dalhousie Univ, Halifax, NS, Canada
[2] Univ Manitoba, Winnipeg, MB, Canada
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2016年 / 111卷
关键词：
D O I：
10.14309/00000434-201610001-00618
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
618
引用
收藏
页码：S284 / S285
页数：2
相关论文
共 50 条
  • [1] THE USE OF 5-ASA IN INFLAMMATORY BOWEL DISEASE: NATIONAL POPULATION BASED STUDY
    Chhaya, V.
    Saxena, S.
    Cecil, E.
    Subramanian, V.
    Curcin, V.
    Majeed, A.
    Pollok, R.
    GUT, 2015, 64 : A444 - A444
  • [2] Safety of chronic 5-ASA use in the elderly inflammatory bowel disease population
    Sommer, Camille
    Feldstein, Richard
    Raju, Shanti
    Mastrine, Lou R.
    Katz, Seymour
    GASTROENTEROLOGY, 2008, 134 (04) : A661 - A661
  • [3] 5-ASA prescription trends over time in inflammatory bowel disease 1996 to 2015-A UK population-based study
    Jairath, V.
    Hokkanen, S.
    Guizzetti, L.
    Boxall, N.
    Campbell-Hill, S.
    Patel, H.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S309 - S310
  • [4] 5-ASA therapy and renal function in inflammatory bowel disease
    Siveke, JT
    Egert, J
    Sitter, T
    Schiemann, U
    Walcher, P
    Torok, HP
    Glas, J
    Folwaczny, C
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (02): : 501 - 501
  • [5] 5-ASA PRESCRIPTION TRENDS OVER TIME IN INFLAMMATORY BOWEL DISEASE 1996-2015-A UK POPULATION-BASED STUDY
    Jairath, Vipul
    Hokkanen, Suvi
    Guizzetti, Leonard
    Boxall, Naomi
    Campbell-Hill, Sarah
    Patel, Haridarshan
    GASTROENTEROLOGY, 2018, 154 (06) : S851 - S851
  • [6] OVERVIEW OF 5-ASA IN THERAPY OF INFLAMMATORY BOWEL-DISEASE
    WILLIAMS, CN
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1994, 8 (06): : 379 - 382
  • [7] Clinical Pharmacology of 5-ASA Compounds in Inflammatory Bowel Disease
    Sonu, Irene
    Lin, Ming Valerie
    Blonski, Wojciech
    Lichtenstein, Gary R.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2010, 39 (03) : 559 - +
  • [8] 5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: Can we afford to wait for 'best evidence'?
    Giannini, EG
    Kane, SV
    Testa, R
    Savarino, V
    DIGESTIVE AND LIVER DISEASE, 2005, 37 (10) : 723 - 731
  • [9] 5-ASA treatment for inflammatory bowel diseases
    Behrens, R
    INFLAMMATORY BOWEL DISEASES AND CHRONIC RECURRENT ABDOMINAL PAIN, 1997, 91 : 135 - 136
  • [10] 5-Aminosalicylate (5-ASA) Induced Nephrotoxicity in Inflammatory Bowel Disease
    So, Kenji
    Bewshea, Claire M.
    Heap, Graham A.
    Muller, Andrew F.
    Delaney, Michael P.
    Daneshmend, Tawfique K.
    Hart, Ailsa L.
    Orchard, Timothy R.
    Irving, Peter M.
    D'Souza, Richard
    Mulgrew, Chris
    Kwan, Jonathan
    Silverberg, Mark S.
    Gearry, Richard B.
    Radford-Smith, Graham
    Watermeyer, Gillian
    D'Inca, Renata
    Annese, Vito
    Tsianos, Epameinondas V.
    Russell, Richard K.
    Wilson, David C.
    Parkes, Miles
    Satsangi, Jack
    Oram, Richard A.
    Weersma, Rinse K.
    Lawrance, Ian C.
    Holden, Arthur L.
    Lees, Charlie W.
    Ahmad, Tariq
    GASTROENTEROLOGY, 2013, 144 (05) : S112 - S112
12345